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mates of resource needs and utilization can be effectively
addressed.
RECOMMENDATIONS
c Care of adults with CHD should be coordinated by
regional ACHD centers that represent a resource for the
medical community.
c An individual primary caregiver or cardiologist without
specific training and expertise in adult CHD should
manage adults with moderate and complex CHD only in
collaboration with a physician with advanced training and
experience in caring for adults with CHD.
c Every academic adult cardiology/cardiac surgery center
should have access to a regional ACHD center for
consultation and referral.
c Every cardiologist should have a referral relationship with
a regional ACHD center.
c Approximately one regional ACHD center should be
created to serve a population of 5 to 10 million people,
with 30 to 50 such centers in the U.S.
c Within a single urban center, institutions should establish
collaborative relationships.
c Each pediatric cardiology program should identify the
ACHD center to which the transfer of patients will be
made.
c An ACHD specialist should evaluate all adults with
moderate and complex CHD at least once. The initial
ACHD evaluation allows stratification of these patients
according to risk and management difficulty.
c Adults with moderate and complex CHD will require
regular evaluations at a regional ACHD center and will
benefit from maintaining contact with a primary care
physician.
c For adults with CHD in the lowest risk group (simple
CHD), cardiac follow-up is recommended at least every
three to five years. The larger group of adults with
moderate and complex CHD will require more frequent
follow-up, generally every 12 to 24 months. A smaller
group of adults with very complex or unstable CHD will
require follow-up at a regional ACHD center at a
minimum of every 6 to 12 months.
c Every adult with CHD should have a primary care
physician. To ensure communication, current clinical
records should be on file both at a regional ACHD center
and with the primary care provider (patients should also
have copies of relevant records).
c All emergency care facilities should have an affiliation
with a regional ACHD center.
c Patients with moderate or complex CHD require admis-
sion or transfer to a regional ACHD center for urgent or
acute care.
c Most cardiac catheterization and electrophysiology pro-
cedures for adults with moderate and complex CHD
should be performed in a regional ACHD center with
appropriate experience in CHD, and in a laboratory with
appropriate personnel and equipment. After consultation
with staff in regional ACHD centers, it may be appro-
priate for local centers to perform such procedures.
c Surgical procedures in adults with CHD as outlined in
Tables 4 and 5 of Task Force #1 should generally be
performed in a regional ACHD center with specific
excellence in the surgical care of CHD.
c Each regional ACHD center should participate in a
medical and surgical database aimed at defining and
improving outcomes in adults with CHD.
c Each regional ACHD center should encourage all
ACHD patient data to be included in a national CHD
database. Programs should work collaboratively on mul-
ticenter projects and develop investigator-initiated re-
search proposals dealing with ACHD.
c The American College of Cardiology should recommend
to the NHLBI and/or Agency for Health Care Research
and Quality the formation of adult congenital centers for
documenting and improving outcomes, education, and
research.
c Each regional ACHD center should establish or affiliate
with a patient advocacy group.
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INTRODUCTION
Access to optimal, specialized, appropriate health care,
health and life insurance, and full employment remains a
problem for many adolescent and adult patients with con-
genital heart disease (CHD) (1).
Health insurance may be difficult to obtain in adulthood
because of “pre-existing conditions”—despite recent federal
legislation—and because of uncertainties and misconcep-
tions about the cost of care for adults with CHD. The actual
costs of medical care appear to be relatively low in these
patients compared with survivors of other chronic diseases
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that begin in childhood (2). The costs in these patients,
compared with the costs in age-matched patients with
adult-onset disease of comparable severity, are unknown.
Federal regulation should provide the opportunity for
individuals with disabilities to seek employment, the major
source of health insurance coverage for most Americans.
The Americans with Disabilities Act does not, however,
require that insurance companies change their underwriting
approaches or assessment of risk. Companies should not
discriminate in hiring on the basis of increased health
insurance costs incurred by the disabled.
Patients with CHD may have difficulty obtaining life
insurance. Life insurance coverage is now generally more
readily available for patients with CHD than it has been in
the past. However, life insurance may be unavailable or
require elevated premiums for patients with CHD, com-
pared with age-matched control subjects, on the basis of
their diagnosis. If financial gain or equity is an issue,
alternatives such as savings plans, mutual fund plans, annu-
ity policies, or other, more standard means of investment,
may offer similar benefits.
Employment of adults with CHD in an appropriate
position and at an appropriate level may require special
counseling, for physical and psychosocial reasons. The use
of professional job training, vocational rehabilitation, and
similar services should be maximized. Recent legislation has
attempted to ameliorate this problem for a broad variety of
individuals, including those with a wide spectrum of med-
ical disorders. However, full, appropriate employment re-
mains an unfulfilled goal for many adults with CHD.
Organized, effective, and passionate advocacy for adoles-
cents and adults with CHD has been lacking, especially
when compared with that of other patients with congenital
anomalies and diseases (e.g., National Organization for
Rare Disorders, Genetic Alliance). Health care providers
and patient groups at local, state, and national levels should
intensify efforts to make the needs of these patients more
visible and to seek innovative, effective solutions to problems
of access.
Access to health care professionals trained appropriately
to treat this patient population also remains a challenge. In
some academic health centers, special clinics focusing on
these patients have been established, but the capacity of
these clinics is not adequate to accommodate this growing
patient group, as discussed earlier in this Conference report.
Access to specialized care in rural areas appears to be a
particularly challenging problem.
COST
Data on cost of CHD: a multicenter study. There are
relatively few studies defining the life-time costs associated
with chronic diseases in children. In 1994, Garson et al. (2)
described a multicenter assessment of lifetime costs of care
for children with CHD. The study aimed to define total
costs associated with the clinical cardiovascular-related care
for children with CHD. To accomplish this cost definition,
the investigators employed clinical functional categories,
with subcategories based on disease severity and treatment
options. They also identified six large clinical care sites
willing to participate in the collection of cost and clinical
practice data, and they extrapolated lifetime costs on the
basis of these data. Physicians in each of the six sites
assigned typical clinical courses to each subcategory. The
clinical outcome was defined by the frequency of seven
services: routine clinic visit, complex clinic visit, hospital
admission for medical treatment, hospital admission for
surgical treatment, hospital admission for interventional
treatment, hospital admission for pacemaker implantation,
and number of years the patient has taken cardiac medica-
tion. Physicians were asked to estimate the percentage of
patients who fell into each clinical category and the number
of services they would need during the first 40 years of their
life. Finally, they were asked to indicate the average charge
for each of the services listed.
This study produced the first reliable data on cost and
practice variation in pediatric cardiology. Both measures
may be used as the basis for increasing control of clinical
practice by a variety of influences (e.g., managed care,
development of clinical practice guidelines).
Findings: cost and variability. This study provides factual
data that can be used to estimate current and future health
care costs. Average charges for care (birth to 40 years of age)
varied from $47,515 to $73,606, or $650 per year. A simple
ratio of charges to mortality was calculated. Although in the
early 1990s charges could be used as a surrogate of cost, this
is no longer the case. However, the study provides statistics
that should be of use to insurers and hospitals in projecting
overall cardiovascular costs across a wide range of ages and
diagnostic categories. It does not take into account noncar-
diovascular costs associated with the care of these children.
For example, general pediatric care costs incurred by these
children were not studied, nor were the costs of respiratory,
physical, or occupational therapy and services providing care
for children with disabilities, as well as other costs.
Although this study made considerable progress toward
identifying cost/benefit ratios based on mortality, the cost/
benefit ratios used to determine the validity of new treat-
ment modalities must also include more refined measures of
morbidity. The need for more refined definitions of mor-
bidity will enhance the ability to define an optimal outcome.
In addition, issues of psychosocial stability, education level,
and employability will more adequately define the value of
the investment in these children.
Garson et al. (2) also identified substantial variability in
practice across institutions. Actual variability in total
charges was not as great as practice differences would
suggest. However, variability in practice patterns contributes
to uncertainty of actual costs.
Some future challenges in assessing costs. YEARLY TREAT-
MENT MODALITY AND OUTCOME VARIABILITY. Estimates
of total service utilization in the study of Garson et al. (2)
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were based on 1992 utilization. Patients born more recently
may have a substantially different outlook from those born
in the early 1970s or before. Thus, estimates of total costs of
the study are most applicable to the present adult population
and have less relevance to infants or children who are
currently under care for cyanotic or acyanotic CHD.
SITE OF OUTPATIENT CARE AND INTERPRACTITIONER
VARIABILITY. The utilization of services and the frequency
of those services may depend on the site of care for adults
with CHD. If a pediatric cardiologist cares for them
exclusively, their care may be quite different from the care
provided by an adult cardiologist, an internist, or an inter-
disciplinary group focused on adults with CHD.
COSTS BESIDES PHYSICIAN CARE. Only estimated direct
medical care costs were included in the study of Garson et
al. (2). Two significant costs were excluded: first, the costs
to the family—loss of work (i.e., income) for parents, costs
of uncovered medical services and drugs, costs of psychol-
ogists, and other costs. Second, there are the societal costs
associated with loss of work, increased health care needs,
and increased educational services. More data on the costs
of care are needed. An update of the type of investigation
conducted by Garson et al. (2) would be most helpful.
INSURABILITY
After over a decade of efforts to obtain insurance coverage
for adults with CHD, some progress has been made, but not
enough. Several possible reasons are suggested.
The population. The unique population of young adults
with heart disease was projected to include over a million
people as we entered the new millennium (3). It was
estimated that, after cardiac surgery, 8,500 young adult
patients reach adulthood each year (3). Many have chronic,
symptomatic cardiac conditions; others are totally asymp-
tomatic, with only mild congenital lesions, such as a small
ventricular septal defect. Many have had surgery, some
expecting further operations. As operative results and post-
operative care continue to improve, the number of young
adults with CHD will undoubtedly continue to increase.
According to the Second Natural History Study, many
patients classified into “simple” diagnostic categories are
appropriately educated or employed, or both (4).
Types of insurance. LIFE INSURANCE. Although it is not
necessarily considered the best long-term financial invest-
ment, life insurance is now considered less of a necessity
than it was a few decades ago, because other investment
vehicles are available. However, some families consider this
a necessary component of their financial planning. Life
insurance is now available to more young people with heart
defects than it was in the past (1,5,6), but it is still more
difficult to obtain for them, compared with individuals with
no health problems (7). The implied risk associated with
different defects is quite variable among different insurance
companies. Some offer standard policies to patients who
have mild pulmonary stenosis or closed or small ventricular
or atrial septal defects, while others increase the premium
rate even for innocent murmurs. They also tend to offer
policies more readily to patients who have passed their 15th
birthday, assuming that passage from childhood lowers their
risk. The cardiologist is often asked to write a letter to the
insurance company about the patient’s condition. The
physician should do so, explaining the long-term expecta-
tions regarding the particular patient. In addition, the family
should be encouraged to apply for insurance from several
companies. Sometimes, using an independent agent will
achieve the best results.
HEALTH INSURANCE. Presently, almost 45 million people
in the U.S. do not have health care coverage. If the patient’s
family is fortunate enough to have health insurance, young
adults with heart disease can be covered as a dependent until
age 19, unless they are still in school or disabled. If more
than half-time schooling is pursued, various companies’
insurance coverage continues until the patient’s 21st or 25th
birthday. If the patient’s status changes (e.g., by marriage),
dependent coverage is often lost. Until age 18 to 21 years,
patients may qualify, depending on income levels, for public
programs such as Medicaid or State Title V, Children with
Special Health Care Needs (CSHCN) Program. The name
of these programs varies from state to state. For a directory
of such programs, including program name, contact infor-
mation, eligibility criteria, and scope of services, refer to the
Directory of State Title V, CSHCN Programs: Eligibility
Criteria and Scope of Services (2000 edition), by John Reiss
and Diana Lamar (editors), Gainesville, Florida: Institute
for Child Health Policy (http://www.ichp.edu). Others who
qualify for Social Security (by virtue of being determined to
be disabled) can obtain Medicare, Part A coverage, but must
purchase Medicare, Part B for 80% physician services (20%
co-pay).
Previous studies have indicated that between 10% and
22% of adults with CHD are uninsured, and 67% have
reported difficulty in obtaining health insurance or changing
jobs to guarantee coverage (8). Those with a history of
surgical repair reported the greatest difficulty, although this
may not correlate with their current severity of illness. Most
commonly, patients can obtain insurance only after the exclu-
sion of cardiac disease as a pre-existing illness, by paying higher
premiums to participate in a high-risk reinsurance pool, or by
obtaining coverage through their employer, in either a health
maintenance organization or self-insured plan.
Types of coverage vary. The common type of coverage 10
to 20 years ago was an independent health care policy. Now
most people have some form of group coverage, usually
purchased through their employer. Most of these plans are
“managed” (i.e., they are linked to a network of participating
physicians and hospitals). In the most developed health
maintenance organization, the choice of physicians is usu-
ally restricted to the network, and a primary care physician
(“gatekeeper”) usually directs care by a specialist (e.g.,
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cardiologist). The gatekeeper may be directed by an inter-
nally developed or nationally developed set of guidelines for
specialty care referral. In the most rigid circumstances, the
gatekeeper may be the health maintenance organization
itself, which may actually direct the referral to the cardiol-
ogist of its choice. In a point-of-service plan or a preferred
provider organization, patients can go freely out of the
network to choose a specialist, with a plan-defined deduct-
ible and co-payment, representing a greater financial re-
sponsibility for the patient, compared with obtaining care
within the network. Within this organizational framework,
it may be difficult for adolescents or adults with CHD to
access care by a skilled cardiologist who is either familiar
with or has expertise in CHD. This can lead to under-
utilization (withholding of specialty access or testing) or
over-utilization (unnecessary testing performed by a cardi-
ologist inexperienced in caring for adults with CHD).
There is a similar obstacle to the team concept that is
crucial in the care of the adolescent and adult patient with
CHD and associated or other health problems. Referral and
reimbursement to multiple subspecialists and mid-level
provider team members may be a new concept for the
insurer, who may not understand and who may reject this
option for the patient. There is a clear need to educate the
insurer about this care delivery model, compared with the
multidisciplinary model that is accepted by most insurers for
the diagnosis and treatment of cancer.
In summary, the current managed care insurance model
does not easily support what may be considered the optimal
care of adults with CHD. There needs to be a recognition by
insurers that the complex range of conditions and the care
needs of adults with CHD are different from those of adults
with acquired heart disease, and current referral and reimburse-
ment models are inadequate to address these differences.
What can be done? In the early 1990s, the Council on
Cardiovascular Disease in the Young, of the American
Heart Association (AHA), held a conference on insurability
of young adults with heart disease (3). Suggestions from
that conference generally apply today and can still be
considered.
As practice guidelines relevant to adults with CHD are
developed, organizations such as the American College of
Cardiology (ACC) should share and discuss these guide-
lines with insurers. Such guidelines should allow insurers to
more accurately project costs of care and to develop appro-
priate premiums.
It was also suggested at the AHA conference (3) that
companies use community standards in the development of
premiums, rather than using small-group standards or a
claims-made standard that penalizes a given patient or
family. The use of clinical practice guidelines should en-
courage the appropriate use of technology, thus further
controlling costs. Training programs should develop strat-
egies to produce a cadre of adequately trained cardiologists
who can provide optimal and cost-effective care to this
population. Uniform coding and billing processes would
greatly reduce paperwork and office/hospital overhead.
Preventive care for pregnant women, which is often not
available to the poor (9), could reduce some cases of CHD
in newborns, as caused by the mother’s alcohol and cocaine
abuse, as well as infections that could have been prevented
by immunization. Prevention of premature birth would also
improve survival and decrease the incidence of some child-
hood diseases. Genetic counseling is also important for
couples whose offspring are at increased risk of CHD.
Over the past two decades, patients have sometimes had
to resort to drastic measures (e.g., quitting work, remaining
in an unsatisfactory position) to maintain health insurance
coverage. Unfortunately, some have elected to avoid clinic
visits, catheterization, or operation because of the personal
financial consequences. Some have died as a result; many
have suffered an unnecessary decline in function. None of
these choices is appropriate or fair.
Since State Title V CSHCN programs cover cystic
fibrosis and hemophilia after the age of 21 years, why not do
so for CHD? This is an avenue that should be pursued.
EMPLOYABILITY AND VOCATIONAL SUPPORT
Employment status. Reports of employment status of
adults with CHD vary. No more than 10% are considered
totally disabled. Those with a mild disability reported a 50%
increased rejection rate in job applications, and those with a
moderate-to-severe disability reported a 400% increase in
rejections of job applications, in comparison with nondis-
abled control subjects. The severity of disability has been
correlated with unemployment and lower income (10).
There have been numerous assessments of employment
status of adults with CHD in the last decade (10,11), with
8% to 13% receiving public assistance or living as a depen-
dent with relatives.
U.S. federal regulations. Existing federal regulations pro-
vide for training and improved prospects for employment of
people considered disabled (e.g., Vocational Rehabilitation
Act). Subsequently, there have been further congressional
acts barring employment discrimination by any federal
employer or employer receiving federal funding (Rehabili-
tation Act of 1973); the U.S. Civil Service (Act of June 10,
1948) and the Americans with Disabilities Act (ADA of
1990), which extends this provision to the private sector, are
two other such acts. Most recently, the Work Incentives
Improvement Act was passed in 1999; this act provides for
a stepped approach to less severely disabled individuals who
could reasonably be expected to be functional and employ-
able with assistance.
The Rehabilitation Act of 1973 also established affirma-
tive action for the advancement of disabled persons, includ-
ing hiring, placement, and vocational rehabilitation. It also
provided for the National Council on the Handicapped to
be formed within the Department of Health, Education and
Welfare. This council was later granted the authority to
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review all federal laws and programs regarding individuals
with disabilities.
The ADA prohibits discrimination with respect to hir-
ing, promotion, or discharge of employees on the basis of
disability. Employers are also required to make accommo-
dations, within reason, to allow a disabled employee to
perform a job. Although the ADA specifically excludes
insurance coverage practices from these injunctions, em-
ployers cannot deny employment on the basis of the
coverage, or lack of coverage, provided by their insurance
benefits, or because their cost of insurance would increase.
The Work Incentives Improvement Act allows for state-
sponsored Medicaid programs to cover some adults who
may be declared “disabled” by virtue of their underlying
condition. The legislation allows states to define the list of
conditions. Therefore, it is possible that a state could define
adults with CHD as “disabled” and eligible for coverage;
this would require each ACC chapter to work with state
Medicaid programs and state legislators to define the
eligibility. The ACC Advocacy Division has resources for
chapters to help in this effort.
Strategies to assist in employment counseling. The most
important element in employment counseling by the health
care provider is an expert, realistic, and assertive estimate of
the patient’s physical capabilities as they relate to available
vocational options. Once this is done, services such as
vocational rehabilitation, job training, and physical rehabil-
itation can be offered. The practitioner should also strongly
consider direct involvement with the employer, at the
patient’s request, to assist in an optimal match between
patient capabilities and job requirements. Despite shortfalls
in legislation and health care coverage, concerted efforts
made by the health care provider can make an enormous
difference in a specific patient’s vocational experience.
ADVOCACY
The ACC has made a strong statement supporting access to
cardiovascular care, regardless of a patient’s ability to pay
(12). Recently, a plan to achieve universal coverage by 2010
was the topic of the ACC Presidential Plenary Address; this
has been published in the Journal of the American College of
Cardiology (13). In the meantime, however, we have today’s
reality and must take incremental steps to provide coverage
for this segment of the population.
Most of these patients are not severely disabled and are
capable of working and contributing to society (8,14).
Despite this, insurance coverage is denied, limited, or
associated with unacceptably high premiums. For example,
through state high-risk pools, premiums for these individ-
uals may exceed standard premiums by as much as 50%,
making this form of insurance inaccessible for many of the
people who need it most. Indeed, as indicated previously,
even those who have insurance face other issues, such as
under-insurance, disapproval by managed care companies of
specific medical services, and life-time caps on coverage.
This population of individuals is particularly vulnerable
because they suffer from conditions they have had all or
most of their lives. They have received coverage and
treatment as children, only to have it taken away at a time
in their lives when they are expected to become self-
sufficient. To complicate matters, these patients, who are
generally capable of working, often have difficulty finding
employment because of their health history.
The ACC’s legislative approach. The ACC leadership
has met with staff at the White House, members of
Congress, and numerous other specialty and patient orga-
nizations to discuss possible mechanisms for providing
health insurance and job training to those with childhood
diseases, including CHD. The ACC presented a resolution
to the American Medical Association (AMA) House of
Delegates; the AMA issued a report in December 1999 (15)
encouraging the government to identify these individuals
and the barriers to their care.
The ACC worked on a popular proposal introduced by
Senator Edward M. Kennedy, D-Mass.; Senator James
Jeffords, R-Vt.; and Rep. Rick Lazio, R-N.Y. Endorsed by
the Administration, this legislation—the Work Incentives
Improvement Act described earlier—provides an incremen-
tal approach to addressing the health insurance needs of the
less severely disabled. The overriding intent of the legisla-
tion is to enable disabled individuals to return to work, but
it also contains a provision that allows state demonstration
projects for people who are less severely disabled and who,
in the absence of needed health care services, would reason-
ably be expected to become disabled. The demonstrations
specifically permit states to offer these individuals a Medic-
aid buy-in option. The ACC worked with legislators to add
to the House Commerce Committee report accompanying
the bill, language that clarifies the congressional intent of
the proposal. The report’s new language says that states
could include in the definition of “potentially severe dis-
ability,” those individuals with congenital birth defects or
other diseases developed in childhood. The ACC key
contacts were alerted, and they provided important support.
The bill was signed into law in 1999. This is an important
first step.
The role of ACC chapters. Individual ACC chapters are
encouraged to take up this issue on behalf of patients with
cardiac diseases. Already, individuals in some states are
considering proposals to fulfill the impending mandates of
the Work Incentives Improvement Act. The ACC has
materials ready to assist chapters in assessing the scope of
the problem in individual states and determining strategies
for communicating with state officials.
The role of individual physicians. Our patients need us to
advise them about what to expect in the real world. We
should tell our patients before they enter adulthood that
their health insurance coverage requires their attention and
should be of concern; they should be advised to seek jobs, as
appropriate, with large employers or the state or federal
government. Our patients should understand that, under
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law, their health status is to have no bearing on employ-
ment; therefore, employers are generally not permitted to
inquire about their condition. This advice can help the
patients we know, but we must also endeavor to help those
we do not know, by working with our legislators to extend
coverage to as many people as possible.
RECOMMENDATIONS
Based on the considerations outlined earlier, the Task Force
recommends that the ACC take the following actions:
General
c Develop a strategic plan for organized advocacy for this
patient population to include health care professionals,
patients, and their families, in the context of a public
relations campaign.
Insurance Coverage and Health Care Costs
c Develop educational materials to guide adolescent and
adult patients in the transition to independence, including
the need for health (and perhaps life) insurance, barriers
that may exist in obtaining coverage, and strategies to
obtain optimal coverage.
c Develop a better understanding of the true economic
impact (e.g., payments, future income potential) of CHD
in adults; this will involve sponsoring a multicenter study
with economic forecasting.
c Include, in formal and regular discussions with insurance
companies and other public and private payors and
purchasers, information on the special problems encoun-
tered and expertise necessary in the care of adolescents
and adults with CHD.
c Reduce the barriers to multidisciplinary services by devel-
oping innovative reimbursement methodologies. Pilot
programs established between one or more ACHD centers
and major payors (public and private) should be encouraged.
c Work, at the chapter level, with state legislators to specify
CHD in a demonstration project of the Work Incentives
Improvement Act.
c Recommend that physicians discuss individual patient
coverage concerns with insurance company medical direc-
tors.
c Advocate health care coverage for all. As an incremental
step, all adults with CHD should be covered, thus
removing a significant barrier to access.
Education, Employability, and Vocational Counseling
c Develop additional educational materials to help adoles-
cent and adult patients as they approach the job market,
focusing on their legal rights (e.g., health should not be
discussed during an interview), tips for success, and where
to go for job training and vocational counseling.
c Recommend that, at the patient’s request, individual
physicians work directly with patients, their schools, and
their employers or potential employers to optimize
opportunities.
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